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USP14 is a deubiquitinating enzyme associated with the proteasome important for protein degrada-
tion. Here we show that upon proteasome inhibition or expression of the mutant W58A-USP14, asso-
ciation of USP14 with the 19S regulatory particle is disrupted. MS-based interactomics revealed an
interaction of USP14 with the chaperone, HSC70, in neuroblastoma cells. Proteasome inhibition
enhanced binding of USP14 to HSC70, and to XBP1u and IRE1a proteins, demonstrating a role in
the unfolded protein response. Striatal neurons expressing mutant huntingtin exhibited reduced
USP14 and HSC70 levels, whereas inhibition of HSC70 downregulated USP14. Furthermore, protea-
some inhibition or use of the mutant W58A-USP14 facilitated the interaction of USP14 with the
autophagy protein, GABARAP. Functionally, overexpression of W58A-USP14 increased GABARAP
positive autophagosomes in striatal neurons, and this was abrogated using the HSC70 inhibitor,
VER-155008. Modulation of the USP14-HSC70 axis may represent a potential therapeutic target in
HD to beneficially influence multiple proteostasis pathways.
INTRODUCTION
USP14 is a deubiquitinating enzyme (DUB) involved in degradation of protein substrates by cleavage and
trimming of ubiquitin chains at the proteasome (Kim and Goldberg, 2017). USP14 is highly expressed in the
nervous system and its deficiency leads to progressive neurological dysfunctions including ataxia and mus-
cle paralysis (Lappe-Siefke et al., 2009). Loss of USP14 is associated with defective ubiquitin recycling and
deficiency in free ubiquitin (Chen et al., 2009). Studies in different cancer cells have revealed a role of USP14
in the degradation of specific protein substrates as shown by the use of chemical blockers (Cai et al., 2017;
Ding et al., 2018). The underlying mechanisms for the various actions of USP14 are not fully understood.
USP14 is a bona fide proteasome-bound protein, but recent studies have established a proteasome-inde-
pendent role of USP14 in the regulation of autophagy in cells (Xu et al., 2016) and in c-jun N-terminal kinase
signaling at the neuromuscular junction (Vaden et al., 2015). Previous studies have further shown that USP14
can interact with inositol-requiring enzyme 1a (IRE1a) on the ER membrane and inhibit ER-associated pro-
tein degradation (Nagai et al., 2009). We recently observed that USP14 is cytoprotective in neuronal cells by
reducing protein aggregates, as observed in models of Huntington disease (HD) (Hyrskyluoto et al., 2014).
Part of this effect evoked by USP14 was ascribed to the ubiquitin proteasome system (UPS) and to the coun-
teraction of IRE1a-mediated ER stress signaling. However, the precise mechanisms underlying the different
cellular roles of USP14 and in the pathology of various diseases are not fully understood.
In thepresentwork,wehaveusedaproteomicapproach to search for interactingpartnersofUSP14 in the context
of neuronal cells. To study the complementary roles of USP14 in a proteasome-free context, we constructed UBL
domainmutant USP14 with a reduced ability to bind to PSMD2/RPN1 in the proteasome 19S regulatory particle
(RP).Wesubsequentlyutilized inhibitorsofproteasomecausingdissociationofUSP14 fromPSMD2,acomponent
of the proteasome 19S RP. Upon proteasome inhibition, USP14 interacted with HSC70/HSPA8 in neuronal cells,
whereas the UBL mutant, W58A-USP14, bound the chaperone avidly even without proteasome blockage. The
small molecule compound, VER-155008, that inhibits HSC70 affected the levels of USP14 in cells, and the inter-
action of USP14 with HSC70 reciprocally regulated their protein levels. Furthermore, we showed that USP14
can interact with other proteins in the cell, including unspliced X-box binding protein-1 that forms aggresome-
like induced structures (called ALIS) in the neuronal cells following proteasome inhibition. These structures
were sensitive to HSC70 inhibition by VER-155008 and the levels of USP14, as shown in neuroblastoma cell lines
after downregulation of USP14 using shRNA. In mutant huntingtin (Htt)-expressing striatal cells with reducediScience 23, 100790, January 24, 2020 ª 2019 The Author(s).
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USP14 levels, the XBP1u positive ALIS also decreased. As reported earlier, USP14 also interacted with the ER
signaling protein, IRE1a, affecting its phosphorylation status and endonuclease splicing activity albeit differen-
tially upon proteasome inhibition. Most significantly, USP14 interacted with the autophagy-linked protein
gamma-aminobutyric acid receptor-associated protein (GABARAP) involved in the late stage of autophagy
(Weidberg et al., 2010b). We observed that the UBL mutant, W58A-USP14 promoted the formation of
GABARAP-positive autophagosomal structures in striatal neuronal cells, a process that was reduced by the
HSC70 inhibitor, VER-155008. Together these data demonstrate that USP14 and its interactionwith HSC70 affect
autophagy and other cellular processes in neuronal cells.RESULTS
USP14 Interacts with the Proteasome 19S Subunit PSMD2 via the UBL Domain
USP14 is an important proteasome-associated DUB that removes ubiquitin chains from protein substrates
destined for degradation. However, USP14may also have non-proteasomal functions by binding to specific pro-
teins in the cell as shown for the IRE1a in the ER membrane (Hyrskyluoto et al., 2014; Nagai et al., 2009). The
mechanisms and factors governing the de-attachment of USP14 from the proteasome are not fully understood.
Weobserved that lactacystin (a chemical compound that inhibits the proteasome) caused release of USP14 from
PSMD2 in the proteasome 19S RP in SH-SY5Y human neuroblastoma cells (Figure 1A). To study the structural
requirement for USP14 binding to the proteasome 19S subunit, we focused on the amino-terminal ubiquitin-
like domain (UBL) with a stretch of amino acids 54-60 that is conserved between species (Figure 1B). Amino
acid 58 (tryptophan, W) in the UBL domain was subsequently mutated to alanine (A) to generate the USP14
mutant construct, W58A-USP14 (Figure 1C). Immunoprecipitation experiments in SH-SY5Y neuroblastoma cells
using the Flag-tagged USP14 constructs revealed that wild-type USP14 avidly interacted with the protein
PSMD2/RPN1 of the proteasome 19S RP, whereas the UBL-mutant W58A-USP14 construct did not (Figure 1D).
In order to investigate the catalytic activity of the generated mutant, we employed the ubiquitin-vinyl methyl
ester (Ub-VME) substrate assay (Borodovsky et al., 2002). Themutant USP14 construct showedno significant deu-
biquitinating activity in this assay performed with mouse neuroblastoma cells (Figure 1E). In contrast, wild-type
USP14 was active as indicated by the presence of an additional band corresponding to the Ub-VME substrate
bound to the catalytic site of USP14 (Figure 1E, arrow). These results show that amino acid 58 in the UBL region is
vital for the interaction of USP14 with the PSMD2/RPN1 in the proteasome 19S RP.Identification of HSC70 as Interacting Partner of USP14
In order to identify USP14 interacting partners, we designed a proteomics strategy using a novel mamma-
lian retroviral-based expression vector pES-NTAP-Puro (a modified version of pCeMM-NTAP(SG)-Gw
vector, EURO-SCARF) (see Transparent Methods). We generated USP14-NTAP-Puro stably expressing
SH-SY5Y cell lines and employed tandem affinity purification (TAP) (Burckstummer et al., 2006) followed
by tandem MS sequencing, bioinformatic analysis, and functional validation of selected interacting part-
ners for USP14 (Figure S2) (Scifo et al., 2013, 2015). The details of NTAP-puro construction, in which the
IRES-GFP cassette has been replaced with IRES-Puro, allowing selection on puromycin are shown in
Figure S1. The functionality of pES-NTAP-Puro was verified by cloning and expression of human USP14
in SH-SY5Y cells. Following SAINT filtering, we identified in total 26 USP14 IP, 23 of which form the 26S pro-
teasomal assembly (Figure 2A). A list of the USP14 IP, isolated from SH-SY5Y USP14-NTAP-Puro stable
cells, is shown in Table S1. Nineteen (73%) USP14 high-confidence IP (HCIP) were previously determined
by a variety of methods including affinity-capture MS, affinity-capture Western, or co-fractionation
(Biogrid/homo-sapiens/usp14). In addition, we identified HSPA8/HSC70, heat shock 71 kDa protein 8 as
an interactor of USP14 (Figure 2A and Table S1). In order to functionally validate the interaction of
USP14 with HSC70, SH-SY5Y cells stably expressing Flag-HA-GFP and Flag-HA-WT-USP14 were gener-
ated. The cells were lysed and protein levels of HSC70 analyzed using immunoblotting. Stable expression
of WT-USP14 increased the protein levels of HSC70 (Figure 2B). Furthermore, transient overexpression of
WT-USP14 in neuroblastoma cells also increased HSC70 protein levels, and this effect was more pro-
nounced for the W58A-USP14 mutant (Figure 2C). These results indicate that the interaction of USP14
with HSC70 increases the protein levels of the latter probably affecting its multiple cellular functions.Inhibition of Proteasome Affects the Interaction of USP14 with HSC70
To validate our findings on HSC70, we carried out co-immunoprecipitation experiments using theW58A-USP14
mutant, transiently expressed in SH-SY5Y cells. In these experiments, themutantW58A-USP14 readily interacted
with HSC70, whereas, WT-USP14 exhibited less ability to bind to the chaperone (Figure 2D). To investigate2 iScience 23, 100790, January 24, 2020
Figure 1. Proteasome Inhibition Disrupts the Association of USP14 with PSMD2 in the Proteasome 19S Subunit
(A) SH-SY5Y cells overexpressing Flag-WT-USP14 were treated with DMSO or lactacystin (5 mM, 6 h) and subjected to
immunoprecipitation. The complexes were analyzed by immunoblotting for PSMD2 of the proteasome 19S regulatory
particle and Flag. Densitometry ratio of the PSMD2-USP14 interaction is presented in the right panel.
(B) Protein sequence of USP14 UBL domain is conserved among species.
(C) Tryptophan (W) mutated to alanine (A) in W58A-USP14 sequence is underlined.
(D) Immunoprecipitation of Flag-WT-USP14 or Flag-W58A-USP14 constructs with Flag antibody and analyzed by
immunoblotting for PSMD2 and Flag.
(E) Cell lysates of Neuro2A cell overexpressing Flag-WT-USP14, Flag-C114A-USP14, or Flag-W58A-USP14 were
incubated with the Ub-VME substrate for 3 h to assess DUB activity. Themixture was analyzed by immunoblotting for Flag,
to detect the substrate-bound DUBs (shows as an additional band on the IB, marked by an arrow; star marks the
overexpressed Flag constructs).
Abbreviations: USP14, ubiquitin-specific protease-14; WT, wild-type; PSMD2, 26S proteasome regulatory subunit 2; UBL,
ubiquitin-like; Ub-VME, ubiquitin-vinyl methyl ester; DUB, deubiquitinating enzyme; IB, immunoblotting; IP,
immunoprecipitation. (A) n = 3, **- p% 0.01 Student’s t-test.whether the association ofWT-USP14withHSC70may require some additional stimulus, we usedbortezomib to
inhibit theproteasome (Figure 2E). Uponproteasome inhibition, the associationof USP14withHSC70was clearly
increased (Figure 2E, lane 3). This is likely related to the fact that inhibition of the proteasome liberates more
USP14 from its binding to PSMD2 in the proteasome 19S RP (Figure 1). Thus, our findings indicate that protea-
some inhibition induced an increase in association ofWT-USP14 with HSC70. To further corroborate the interac-
tion of USP14 and HSC70, we overexpressed Flag-USP14 constructs in conjunction with GFP-WT-HSC70 in
SH-SY5Y cells followed by immunoprecipitations. The resulting IP complexes were analyzed by immunoblotting
with anti-Flag and anti-GFP antibodies. GFP-WT-HSC70 co-immunoprecipitated with Flag-WT-USP14 and the
interaction was increased in the presence of MG132 (Figure 2F). Mutant W58A-USP14 exhibited a high inherent
ability to associatewithHSC70, exceeding that observedwithWT-USP14 after proteasome inhibition (Figure 2F).
Together these results show that the interaction of USP14 with HSC70 in neuroblastoma cells is sensitive to pro-
teasome inhibition.
USP14 Interacts with XBP1u Protein upon Proteasome Inhibition
We and others have previously shown that USP14 can bind to the ER(ER)-resident kinase, IRE1a, affecting its
phosphorylation status in models of HD (Hyrskyluoto et al., 2014). Activation of IRE1a mediates variousiScience 23, 100790, January 24, 2020 3
Figure 2. Proteasome Inhibition or Expression of Mutant W58A-USP14 Enhances the Association of USP14 with
HSC70
Affinity purification and bioinformatic analysis of USP14-interacting partners were performed as depicted in Figure S2.
(A) The identified USP14-interacting partners are depicted figuratively where most of the hits constitute the 26S
proteasome complex and have previously been reported. The interaction of USP14 with HSPA8/HSC70 is depicted
separately.
(B and C) SH-SY5Y cell lines (B) stably expressing Flag-HA-USP14 and Flag-HA-GFP, (C) transiently expressing wild-type
and mutant USP14 construct (WT-USP14 and W58A-USP14) were analyzed by immunoblotting for HSC70 and Flag
expression. Actin served as loading control.
SH-SY5Y cells overexpressing various USP14 constructs were treated with drugs and analyzed for the interaction with
HSC70.
(D) Flag-WT-USP14 and Flag-W58A-USP14 constructs.
(E) Flag-WT-USP14 and treatment with the proteasome inhibitor, bortezomib (0.5 mM, 6 h). Treatment with DMSO was
used as a negative control.
(F) Flag-WT-USP14 or Flag-W58A-USP14 co-expressed with GFP-WT-HSC70 were treated with MG132 (20 mM, 6 h) or
DMSO (negative control) and subjected to IP with anti-Flag antibodies.
The immunoprecipitated complexes were analyzed by IB for HSC70 and Flag (D and E) and for GFP, and Flag (F) values
represent meansG SEM, n = 3. (B) p value was calculated by student’s t-test and (C) one-way ANOVA. *p% 0.05; ****p%
0.0001.
FASP, filter-aided sample preparation; nanoLC-MS/MS, nano-liquid chromatography coupled tandem mass
spectrometry; Co-IP, co-immunoprecipitation; SAINT, significance analysis of interactome; USP14, ubiquitin-specific
protease-14; WT, wild-type; IB, immunoblotting; HSPA8/HSC70, heat shock cognate 71 kDa protein; HA, hemagglutinin
tag; GFP, green fluorescent protein.
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signaling cascades during UPR and ER stress including the splicing of the X-box binding protein 1 (XBP1)
mRNA producing the transcription factor XBP1s (Lee et al., 2008). The unspliced mRNA is still translated
into a functional protein (called XBP1u, unspliced XBP1) in higher order eukaryotes (Tirosh et al., 2006).
To investigate whether USP14 interacts with the XBP1 proteins, we studied endogenous USP14 in primary
cortical neurons (Do et al., 2013). As shown by immunoprecipitation, USP14 interacted with XBP1, but only
with the 29 kDa, unspliced XBP1 form (XBP1u, marked with a red star in Figure 3A) under normal conditions,
and this interaction wasmore pronounced uponMG132-induced proteasome inhibition (Figure 3A, lane 2).
To further assess this interaction, co-immunoprecipitation experiments were performed in SH-SY5Y cells
expressing Myc-DDK-XBP1u followed by immunoprecipitation using anti-Flag antibody. XBP1u preferen-
tially interacted with USP14 under conditions of proteasome inhibition by MG132 (Figure 3B). This interac-
tion was more pronounced by overexpression of WT-USP14 leading to the appearance of HSC70 in the
formed immunocomplex (Figure 3B, lane 4). This suggests the existence of a tri-partite complex of
XBP1u, USP14, and HSC70 present after proteasome inhibition in the cells. Next, we performed immuno-
precipitation experiments in SH-SY5Y cells using Flag-tagged USP14 constructs showing that WT-USP14
and the UBL-mutant, W58A-USP14, did not significantly bind XBP1u under unstressed control conditions
(Figure 3C, lane 1 and 4). However, upon proteasome inhibition that elevates XBP1u, there was a clear inter-
action of XBP1u with WT-USP14 (Figure 3C, lane 3). In these experiments, addition of tunicamycin did not
induce the USP14-XBP1u interaction. These results reveal that USP14 interacts with XBP1u upon inhibition
of the proteasome with potential functional consequences on ER stress regulation and crosstalk between
different cellular processes.
XBP1u Forms Aggresome-like Induced Structures upon Proteasome Inhibition in
Neuroblastoma Cells
Based on the findings above, we investigated the dynamics of XBP1u upon proteasome inhibition. Toward
this goal, SH-SY5Y cells were treated with MG132 or the lysosomal inhibitor, chloroquine, followed by
immunoblotting using anti-XBP1 antibody (representative immunoblot in Figure 4A depicts XBP1u de-
tected by XBP1 antibody). MG132 induced a robust increase in protein levels of XBP1u, whereas chloro-
quine treatment had a minor effect on XBP1u (Figure 4A). To clarify whether USP14 influences the increase
in XBP1u upon proteasome inhibition, we expressedGFP-WT-USP14 in neuroblastoma cells further treated
with either MG132 or bortezomib (Figure 4B). USP14 overexpression did not affect the protein levels of
XBP1u induced by these inhibitors (Figure 4B). Next, immunostainings using specific anti-XBP1u antibody
were performed to assess the cellular localization of XBP1u in control and proteasome-inhibited SH-SY5Y
cells (Figure 4C). We observed that XBP1u was present in aggresome-like induced structures (named here
ALIS) in the MG132-treated neuroblastoma cells. We then generated stable SH-SY5Y cell lines with down-
regulation of USP14 using specific shRNA constructs, whereas control cells were created using scrambled
shRNA. The level of USP14 protein in the USP14-shRNA cell lines was efficiently downregulated, by70%–
80% in comparison to control cells. Most significantly, the increase in XBP1u induced by MG132 was signif-
icantly reduced in the USP14-deficient cells (Figure 4D). Together, these findings demonstrate that XBP1u
accumulates in neuroblastoma cells after proteasome inhibition and that XBP1u levels are affected by the
expression of USP14.
USP14 Levels Affect IRE1a Phosphorylation and Splicing of XBP1
It was previously reported that XBP1u nascent polypeptide can influence the localization of its own mRNA
to the ERmembrane, facilitating the generation of spliced XBP1 by IRE1a (Yanagitani et al., 2009). Given the
role of USP14 in regulation of XBP1u levels, we investigated the function of USP14 in modulating IRE1a
response following proteasome inhibition. Overexpression of Flag-WT-USP14 in SH-SY5Y cells followed
by immunoprecipitation showed that USP14 interacts with IRE1a upon proteasome inhibition (Figure 5A).
The interaction following tunicamycin treatment was also detected, but to a significantly lesser degree,
whereas the effect of MG132 was more pronounced (Figure 5A). Treatment of USP14-shRNA knock-
down cell lines withMG132 produced a large increase in the phosphorylation of IRE1a as shown by the ratio
of phosphorylated to total IRE1a (Figure 5B). The level of spliced XBP1 (XBP1s) was also increased following
MG132 treatment; however, this increase was reduced in the USP14-deficient neuroblastoma cells
(Figure 5B). Next, we investigated the effects of tunicamycin in the USP14-shRNA knock-down cell lines.
Addition of tunicamycin for 6 h induced IRE1a phosphorylation and XBP1s reflecting the activation of
the UPR (Figure 5C). In contrast to MG312, the effect of tunicamycin on IRE1a phosphorylation was reduced
in USP14-deficient cells (Figure 5C), whereas the level of XBP1s was the same in control and USP14 down-
regulated cells treated with tunicamycin. This shows that the downregulation of USP14 differentially affectsiScience 23, 100790, January 24, 2020 5
Figure 3. USP14 Associates with XBP1u upon Proteasome Inhibition
(A) Rat primary cortical neuronswere treated for 6 hwithMG132 (20 mM)orDMSO, lysed, and subjected to IP utilizing anti-USP14
antibody. Right panel depicts a histogram for the densitometry ratio XBP1u (red *)-USP14 interaction in the pull down.
(B) SH-SY5Y cells overexpressingMyc-DDK-XBP1u and treated for 6 h with MG132 (20 mM) in the presence and absence of
GFP-WT-USP14 were subjected to IP with anti-Flag antibody. Treatment with DMSO served as a negative control.
(C) SH-SY5Y cells overexpressing Flag-WT-USP14 or Flag-W58A-USP14 were treated for 6 h with MG132 (20 mM) or
tunicamycin (2.5 mg/mL) and immunoprecipitated with anti-Flag antibody. Treatment with DMSO served as negative
control. Right panel depicts a histogram for the densitometry ratio of XBP1u normalized to Flag in the pull down.
The complexes were analyzed by immunoblotting for (A) USP14 and XBP1 (XBP1u) (B) USP14, HSC70, and XBP1 (XBP1u),
(C) XBP1 (XBP1u), and Flag. XBP1u-unspliced X-box-binding protein 1. (A) n = 4, (C) n = 3. p value was calculated by
student’s t-test (A and C). *p % 0.05; ***p% 0.001.IRE1a signaling in the cell upon proteasome inhibition, increasing the degree of IRE1a phosphorylation,
whereas reducing the levels of XBP1s.
USP14 Is Reduced in Striatal Neurons Expressing Mutant Htt Cells
We previously observed that overexpression of USP14 decreased the amount of mutant Htt aggregates in
neuronal cells, partly due to its beneficial effects on reducing ER stress (Hyrskyluoto et al., 2014). However,
the role of endogenous USP14 in striatal neurons that are the main target in HD remained unclear.
To resolve this, we cultured striatal cells expressing endogenous wild-type Htt (7Q repeats) or mutant6 iScience 23, 100790, January 24, 2020
Figure 4. XBP1u Is Increased upon Proteasome Inhibition and Forms ALIS Structures in Cells Regulated by USP14
(A) SH-SY5Y cells treated with MG132 (20 mM), chloroquine (50 mM), or DMSO (negative control) for 6 h were analyzed by
immunoblotting for the presence of XBP1u detected by XBP1 antibody. Lower panel depicts densitometry histograms for
the value of XBP1u normalized to actin.
(B) SH-SY5Y cells transfected with GFP-WT-USP14 or empty vector were treated withMG132 (20 mM), bortezomib (0.5 mM),
or DMSO for 6 h (negative control) and analyzed for the presence of XBP1u. Immunodetection with anti-GFP and anti-
actin served as transfection and loading controls, respectively. Lower panel shows XBP1u normalized to actin.
(C) SH-SY5Y cells treated with MG132 (20 mM) or DMSO for 6 h were fixed and stained with anti-XBP1u antibodies. Note
presence of immunopositive aggregates, named aggresome-like induced structures (ALIS, green). Nuclei were stained
by Hoechst dye (blue). Scale bar, 100 mm.
(D) USP14 shRNA and scramble shRNA lentivirus-infected SH-SY5Y cells were treated with MG132 (20 mM) or DMSO for 6
h. The lysates were analyzed by IB for XBP1 (XBP1u), actin, and USP14. Right panel depicts a histogram for the
densitometry ratio of XBP1u normalized to actin.
n = 3, p value was calculated by one-way (A and D) or two-way ANOVA (B). *p% 0.05; ***p% 0.001, ****p% 0.0001.
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Figure 5. USP14 Differentially Regulates IRE1a upon Proteasomal Inhibition
(A) SH-SY5Y cells overexpressing Flag-WT-USP14 or Flag-W58A-USP14 and treated for 6 h with MG132 (20 mM) or
tunicamycin (2.5 mg/mL) were subjected to IP with anti-Flag antibodies. Immunoprecipitated complexes were analyzed
for the presence of IRE1a and Flag.
USP14 shRNA and scramble shRNA lentivirus-infected SH-SY5Y cells were treated with (B) MG132 (20 mM) or (C)
tunicamycin (2.5 mg/mL) for 6 h. Treatment with DMSO served as negative control. The lysates were analyzed for the
presence of IRE1a, p-IRE1a, and XBP1s (detected by XBP1 antibody). Immunodetection with anti-USP14 and anti-actin
served as a control for silencing efficiency and loading control, respectively. (B) Lower panel depicts densitometry
histograms for the ratio of p-IRE1a normalized to total IRE1a and XBP1s normalized to actin. (C) Densitometry ratio of p-
IRE1a normalized to total IRE1a.
(B and C) n = 3, p value was calculated by two-way ANOVA. *p% 0.05; **p% 0.01. IRE1a, inositol-requiring protein 1a;
XBP1s, spliced X-box-binding protein 1; pIRE1a, phosphorylated IRE1a.
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Figure 6. Striatal Cells Expressing Mutant Htt Have Reduced Levels of USP14, HSC70, and XBP1u Aggregates
(A) Striatal cells expressing 7Q (control) and 109Q (mutant) huntingtin (Htt) were subjected to immunoblotting for USP14,
HSC70, and GAPDH. Lower panels represent histograms of the densitometry ratios of USP14 and HSC70, normalized to
GAPDH.
(B) Striatal cells expressing 7Q or 109Q Htt were treated with MG132 (20 mM, 6 h) or DMSO (control) followed by
immunoblotting for XBP1u using anti-XBP1 antibody. Right panel represents the histogram for the densitometry ratio of
XBP1u normalized to GAPDH.
(C) qPCR was done as described in Transparent Methods. Note reduced expression of USP14 in 109Q Htt cells compared
with 7Q Htt cells. Gene expression was normalized to GAPDH and controls set to 1.
(D) Striatal cells were immunostained for XBP1u to show presence of XBP1u-positive ALIS induced by MG132. Note
reduced immunostaining in 109QHtt cells compared with 7QHtt cells. Right panel represents a histogram for the average
integrated intensity per XBP1u particle. Nuclei were stained by Hoechst dye (blue). Scale bar, 100 mm.
In (A–D, except C) n = 3, (C) n = 5, (A–D) p value was calculated by Student’s t-test. *p% 0.05, **p% 0.01, ***p% 0.001.
7Q, 7-polyglutamine repeats; 109Q, 109-polyglutamine repeats; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.Htt (109Q repeats) proteins (Kannike et al., 2014; Zuccato et al., 2003). Immunoblotting showed that USP14
levels together with HSC70 were reduced in striatal cells expressing mutant 109Q Htt compared with con-
trols (Figure 6A). Quantitative PCR analyses done as in Pham et al. (2019) revealed that USP14 expression
was also lowered inmutant Htt cells (Figure 6C). As in neuroblastoma cells (Figure 4), treatment withMG132
induced an increase in XBP1u in control striatal cells (Figure 6B). However, this increase was significantly
less pronounced in mutant Htt-expressing cells (Figure 6B). Immunostaining of these cells revealed that
the formation of XBP1u containing ALIS induced by MG132 was also reduced in mutant Htt cells
(Figure 6D).
Inhibition of HSC70 Reduces the Cell Viability and Downregulates USP14 in Striatal Cells
Earlier reports on the role of HSC70 chaperone in neurodegenerative diseases revealed its function in
disaggregating misfolded proteins and in autophagy processes (Scior et al., 2018; Tekirdag and Cuervo,
2018). To study the role of HSC70 in interaction with USP14, we employed VER-155008, a small moleculeiScience 23, 100790, January 24, 2020 9
Figure 7. Chemical Inhibition of HSC70 with VER-155008 Causes Cell Death in Striatal Neuronal Cells and
Downregulates USP14 Protein Levels
(A) Striatal cells expressing 7Q or 109Q Htt were treated with VER-155008 (25 mM or 50 mM, 24 h). Cell viability was
assessed with MTT as described in Transparent Methods.
(B) Striatal 7Q Htt cells were stimulated with VER-155008 (25 mM, 24 h) and the lysates analyzed for the presence of USP14.
Right panel shows histogram for the densitometry ratio of USP14 normalized to GAPDH.
(C) Striatal cells were immunostained for XBP1u to show the effect of VER-155008 on MG132-induced XBP1u ALIS in 7Q
Htt-expressing cells. Nuclei were stained by Hoechst dye (blue). Scale bar, 100 mm.
p value calculated by two-way ANOVA n = 4 (A), Student’s t-test n = 3 (B). *p% 0.05, **p% 0.01, ****p% 0.0001. MTT, 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
Nuclei were stained by Hoechst dye (blue). Scale bar, 100 mm.inhibitor of HSC70 (Yang and Tohda, 2018). VER-155008 induced a significant amount of cell degeneration
in cultured striatal cells in a dose-dependent manner, andmutant cells expressing 109Q Htt were generally
more vulnerable to the effect of VER-155008 (Figure 7A). Treatment with VER-155008 also reduced the level
of USP14 in the striatal cells (Figure 7B). Further corroborating the role of HSC70 in USP14 dynamics, VER-
155008 downregulated the XBP1u ALIS structures in striatal cells following proteasome inhibition (Fig-
ure 7C). Taken together, these results show that inhibition of HSC70 by VER-155008 reduced viability of
striatal cells in conjunction with a decrease in USP14 and with an influence on MG132-induced XBP1u ALIS.
W58A-USP14 Interacts with GABARAP and Enhances the Formation of GABARAP Positive
Autophagosomes that Are Regulated by VER-155008
Proteasome inhibition has been linked to an increase in compensatory autophagy establishing a functional
crosstalk between the two cellular processes (Kim et al., 2018; Kocaturk and Gozuacik, 2018; Sha et al.,
2018). Several proteins including the autophagy-related protein 8 (Atg8) family, involved in the formation10 iScience 23, 100790, January 24, 2020
Figure 8. Proteasome Inhibition or Expression of Mutant W58A-USP14 Increases Association of USP14 with
GABARAP in Neuronal Cells
(A) SH-SY5Y cells overexpressing Flag-WT-USP14 or Flag-W58A-USP14 together with EGFP-GABARAP were treated
with MG132 (20 mM, 6 h) and subjected to IP with anti-Flag antibody. The complexes were analyzed by immunoblotting
using anti-GFP and anti-Flag antibodies. Red arrow indicates IgG heavy chain band. Blue arrow indicates Flag-USP14.
(Red *)—pro form of GABARAP (GABARAP-I), (Red **)—mature form of GABARAP (GABARAP-II).
(B) Primary cortical neurons were treated with MG132 (20 mM, 6 h) or DMSO and subjected to IP with anti-USP14 antibody.
The complexes were analyzed with anti-GABARAP and anti-USP14 antibodies. Red arrow indicates IgG heavy chain band.
Blue arrow indicates USP14.
(C) Striatal 7Q cells were treated with MG132 (20 mM, 6 h) or DMSO and subjected to IP with anti-USP14 antibody. The
complexes were immunoblotted for anti-GABARAP and anti-USP14 antibodies. Red arrow indicates IgG heavy chain
band. Blue arrow indicates USP14.
In (B and C) right panel represents histogram for the densitometry ratio of GABARAP to USP14 in the pull down.
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Figure 8. Continued
(D) Striatal cells expressing 7Q (control) and 109Q (mutant) Htt were subjected to immunoblotting for GABARAP. Right
panel represents histograms for the densitometry ratio of GABARAP-II/GABARAP-I.
(E) Striatal cells expressing 7Q and 109Q Htt and transfected with Flag-W58A-USP14 were stimulated with bafilomycin
(200 nM, 6 h). Cell lysates were analyzed with IB for anti-GABARAP and anti-Flag.
In (B–D) n = 3, p value was calculated by Student’s t-test. **p% 0.01, ***p% 0.001. GABARAP- GABA type A receptor-
associated protein.of the autophagosomal membrane at different stages, regulate autophagy. Mammalian Atg8 genes
consist of three subfamilies: microtubule-associated protein 1 light chain 3 (LC3), g-aminobutyric-acid-re-
ceptor-associated protein (GABARAP) and Golgi-associated ATPase enhancer of 16 kDa (GATE-16)
(Shpilka et al., 2011). Using co-immunoprecipitation, we studied whether USP14 can interact with
GABARAP, which is involved in the maturation of autophagosomes. Results showed that there was a
weak interaction of GABARAP with WT-USP14 in the neuroblastoma cells under normal conditions
(Figure 8A, lane 1). However, the strength of the interaction was more pronounced upon proteasome inhi-
bition using MG132 (Figure 8A, lane 2), and the UBL-mutant, W58A-USP14, avidly interacted with
GABARAP even without addition of MG132 (Figure 8A, lane 3). Validation of the protein interaction was
achieved in primary cortical neurons (Figure 8B) and striatal neuronal cells (Figure 8C), corroborating
that proteasome inhibition increased the association of endogenous USP14 with GABARAP compared
with controls (lane 1, Figures 8B and 8C). To study the functional consequences of the USP14-GABARAP
interaction, we focused on the striatal neuronal cells expressing either 7Q Htt or 109Q mutant Htt. Immu-
noblotting revealed that GABARAP was downregulated in the 109Q Htt cells (Figure 8D). GABARAP, as
other ATG8 family proteins, is processed to a mature form GABARAP-II, aiding in autophagosome forma-
tion, and this was reduced in the mutant 109Q cells, as shown by the densitometric ratio of GABARAP-II
(mature form) to GABARAP-I (pro form) (Figure 8D, lane 3 and 4; right panel histogram). Bafilomycin is
known to block the fusion of autophagosomes and lysosomes. Striatal 7Q-cells expressing W58A-USP14
and treated with bafilomycin displayed an increased conversion of GABARAP during autophagy (Figure 8E,
lane 4), indicating that W58A-USP14 could regulate this process. However, in the 109Q mutant Htt cells,
there was no clear increase in GABARAP processing in the presence of neither W58A-USP14 nor bafilomy-
cin (Figure 8E, lane 8). To investigate this further, we used live cell imaging of EGFP-GABARAP positive
puncta as representative of autophagosomes present in the striatal cells after different treatments (Figures
9A–9C). Striatal 7Q-expressing cells exhibited more GABARAP-positive puncta compared with 109Q-ex-
pressing cells (Figures 9A–9C). Addition of chloroquine to block lysosomal degradation increased the num-
ber of these structures, particularly in control 7Q-expressing cells (Figure 9A). W58A-USP14 expression also
increased the GABARAP-positive puncta, which was further elevated by the addition of chloroquine
(Figure 9A, panels 3 and 4). Next, we studied whether HSC70 could play a role in the W58A-USP14 medi-
ated increase in GABARAP-positive puncta. Addition of VER-155008 to inhibit HSC70 blocked the increase
in GABARAP-positive puncta that arose fromW58A-USP14 expression (Figure 9B, panels 2 and 3). To study
the GABARAP positive autophagosomal structures at a higher resolution we then employed the Nikon
Eclipse Ti-E inverted wide-field microscope equipped with an environmental chamber (see Transparent
Methods). This set of imaging confirmed the increase in GABARAP-positive puncta by W58A-USP14
(Figure 9C, panel 2), as well as the decrease following the inhibition of HSC70 with VER-155008 (Figure 9C,
panel 2 and 3). Together the live cell experiments demonstrate that HSC70 can influence GABARAP-pos-
itive puncta in the striatal cells and likely so via its interaction with USP14. The results further suggest that
mutant Htt-expressing striatal cells have a defect in autophagy at the GABARAP-mediated autophago-
some maturation level. As shown here this can be modulated by USP14 and HSC70 proteins, which can
be of significance in HD and other neurodegenerative diseases accompanied by a dysfunctional
autophagy.
DISCUSSION
In this work, we demonstrate that USP14 plays a role in regulation of autophagy and UPR in neuronal cells.
The basis for this is the ability of USP14 to constitute functional protein-protein interactions with key
signaling molecules in the cell. The precise nature of such modules involving USP14 has so far remained
elusive except for reports on the binding of USP14 to Beclin-1 (Xu et al., 2016), c-Jun (Vaden et al.,
2015), and IRE1a (Hyrskyluoto et al., 2014), and the molecular mechanisms associated with these interac-
tions are not fully understood. Using advanced proteomics, we show here that USP14 interacts with the mo-
lecular chaperone HSC70 in human neuroblastoma SH-SY5Y cells, which was functionally validated using
immunoprecipitation and other experiments. The interaction between USP14 and HSC70 was enhanced12 iScience 23, 100790, January 24, 2020
Figure 9. Mutant W58A-USP14 Increases GABARAP Positive Puncta in a HSC70-dependent Manner
(A and B) Striatal cells were transfected with EGFP-GABARAP in combination with an empty vector or Flag-W58A-USP14
and further stimulated with (A) chloroquine (50 mM, 5 h) or (B) VER-155008 (25 mM, 24 h). Live cell imaging was done using
EVOS FL microscope revealing EGFP-GABARAP positive autophagosomes. In (A) right panel represents average
integrated intensity per GABARAP particles depicted as a histogram. Intensity of GABARAP positive autophagosomal
structures was quantified using ImageJ. n = 3. Scale, 100 mM (A and B).
(C) Striatal cells were plated on Ibidi ibitreat polymer bottom wells as described in Transparent Methods and transfected
with EGFP-GABARAP in combination with an empty vector or Flag-W58A-USP14 and stimulated for 24 h with VER-155008
(25 mM). High-resolution live cell imaging with a Nikon-Eclipse Ti-E inverted wide-field microscope equipped with an
environmental chamber was utilized to reveal the EGFP-GABARAP positive autophagosomes, n = 5. Scale, 10 mM.
In (A and C) p value was calculated by two-way ANOVA. *p% 0.05, **p% 0.01, ***p% 0.001, ****p% 0.0001.
EGFP,- enhanced green fluorescent protein.by inhibition of the proteasome that reduced the binding of USP14 to the PSMD2 in the proteasome 19S
RP. We further noticed that USP14 is able to interact with XBP1u and the ER-resident protein IRE1a. These
findings demonstrate that with reduced binding to PSMD2, USP14 can interact with cellular proteins, such
as HSC70, XBP1u, and IRE1a. These protein-protein interactions may have functional consequences in
various human diseases characterized by accumulation of misfolded proteins and an impaired proteasome
function. Particularly in HD and other polyQ diseases, expression of mutant proteins with expandediScience 23, 100790, January 24, 2020 13
repeats can block the proteasome and induce ER stress further exacerbating the disease conditions
(Hyrskyluoto et al., 2013, 2014). Recent work also established that the expanded polyQ repeats inhibit
Beclin-1 mediated autophagy (Ashkenazi et al., 2017). In this work, we have addressed the functionality
of USP14 interactions specifically in the context of striatal neuronal cells expressing mutant Htt protein
with dysregulated proteostasis and autophagy. USP14 is a vital component of the proteasome coordi-
nating the deubiquitylation of protein substrates followed by substrate engagement, leading to protea-
some activation (Peth et al., 2009). The mammalian 26S proteasome consists of two components, 19S RP
and 20S core particle containing several subunits. USP14 binds to the PSMD2/RPN1 protein in the 19S
RP via its N-terminal UBL domain (Aufderheide et al., 2015). Using mutagenesis, we have identified trypto-
phan at position 58 in the UBL domain of USP14 that disrupts the association of USP14 with PSMD2. The
UBL-mutant W58A-USP14 behaved similarly to WT-USP14 upon proteasome inhibition indicating that
they are functionally related. Results obtained with the W58A-USP14 mutant reinforce the concept of
the existence of a dynamic pool of USP14 in the cell, performing proteasome independent functions in
the cell.
To investigate the functions of USP14 independent of the proteasome, we first characterized its role in unfolded
protein response based on its known interaction with the signaling protein IRE1a (Nagai et al., 2009). We have
previously reported that USP14 counteracts the IRE1a-mediated ER stress and increases the clearance ofmutant
Htt in cells (Hyrskyluoto et al., 2014). In this study, we observed that the association of USP14 with IRE1a was
further increased upon proteasome inhibition. Using USP14 knockdown cells we noted that USP14 deficiency
resulted in an enhanced phosphorylation of IRE1a and a decrease in XBP1 splicing activity. This suggests that
USP14 may differentially control the kinase and the RNase domain in IRE1a located at either ends of the mole-
cule. Similar actions on IRE1a involving distinct responses in its structural domains have been reported for small
molecule compounds that are ATP-competitive inhibitors that disrupt the IRE1a kinase function while activating
the RNase domain (Feldman et al., 2016). It would be important to investigate whether the USP14 can serve as a
determinant of IRE1a response upon different stimuli.
Subsequently, we noted that USP14 interacts with unspliced XBP1 (XBP1u) protein upon proteasome inhi-
bition. Compared with spliced XBP1 acting as a transcription factor, less is known about XBP1u in cell phys-
iology. Previous reports have shown that XBP1u is a short-lived protein (Tirosh et al., 2006), and XBP1u, via
translational pausing of its nascent polypeptide, mediates efficient splicing of XBP1 mRNA by activated
IRE1a upon ER stress (Kanda et al., 2016; Yanagitani et al., 2009). We observed that inhibition of the pro-
teasome strongly upregulated XBP1u in neuronal cells with accumulation of the protein in aggresome-
like induced structures, called here ALIS. These have been observed before in HEK 293T cells with no direct
functions reported (Navon et al., 2010). We noted also that XBP1u interacts with USP14 and HSC70, likely
forming a tri-partite complex in neuronal cells.
To investigate whether the ALIS are modulated in HD, we studied striatal cells expressing control 7Q or
109Q mutant Htt protein. To our surprise, we noticed that the mutant Htt expressing cells showed less for-
mation of XBP1u positive ALIS upon proteasome inhibition comparedwith controls. These could be related
to lowered levels of USP14 and HSC70 in themutant cells. Treatment with the HSC70 inhibitor, VER-155008,
reduced the formation of the ALIS in control striatal cells upon proteasome inhibition. Together, these find-
ings indicate that ALIS formation is reduced in mutant Htt expressing cells and that USP14 along with
HSC70 could be involved in their dynamics. Further studies are warranted to pinpoint the functions of
the XBP1u positive ALIS in cell responses and in various diseases, such as HD.
HSC70 is a molecular chaperone that affects diverse cellular pathways by regulating protein folding and degra-
dation ofmisfoldedproteins. Theseprocesses are prone todysfunction in human disorders with accumulation of
misfolded or mutant proteins. In proteostasis, HSC70 is involved in the disaggregation of misfolded protein, in
chaperone-mediated autophagy and inmicroautophagy (Tekirdag andCuervo, 2018). USP14binds Beclin-1 and
inhibits the formation of autophagosomes by removing the K63-linked poly-ubiquitin chains on Beclin-1 (Xu
et al., 2016). We hypothesized that USP14 along with HSC70 may play a role in modulating autophagy. For
this purpose, we focused on GABARAP and its functions in autophagic processes. There are three ATG8
gene subfamilies in mammals, namely, microtubule-associated protein 1 light chain 3 (LC3), g-aminobutyric-
acid-receptor-associated protein (GABARAP), and Golgi-associated ATPase enhancer of 16 kDa (GATE-16)
(Shpilka et al., 2011). GABARAP/GATE-16 is required for the formation of autophagosomes and their maturation
(Weidberg et al., 2010a, 2010b), and further they can regulate GABAA receptor endocytosis, thus influencing14 iScience 23, 100790, January 24, 2020
neuronal signaling function (Hui et al., 2019). The GABAergic medium spiny neurons in the striatum are partic-
ularly affected inHD. Hence, we investigatedwhether GABARAP alongwithUSP14 andHSC70 could specifically
have relevance in striatal neuronal cells expressing Htt.
To begin with, we noted that USP14 in the striatal cells expressing mutant Htt was decreased both at the
mRNA and protein levels. The former may be related to reduced transcription, as accumulation of mutant
Htt in the nucleus is known to affect gene expression; however, this warrants further investigation. We
further observed that the protein levels of HSC70 were downregulated in the mutant Htt-expressing cells,
and these cells were also more vulnerable to the action of VER-155008 inhibiting the activity of HSC70.
These findings may indicate a possible role of HSC70 and its interaction with USP14 in the pathophysiology
of HD. We further observed that the UBL-mutants, W58A-USP14 and WT-USP14, upon proteasome inhibi-
tion could interact with GABARAP in neuronal cells. Striatal neuronal cells expressing mutant Htt exhibited
reduced conversion of GABARAP-I to its mature form, GABARAP-II. This indicated a possible defect in the
GABARAP-mediated autophagosome maturation. To further characterize the physiological relevance of
this we performed live cell imaging and tracking of EGFP-GABARAP positive autophagosomes in 7Q Htt
and 109Q Htt expressing cells. Data showed that the formation of EGFP-GABARAP positive autophago-
somes was downregulated in mutant Htt cells compared with control. Inhibition of lysosomes with chloro-
quine revealed that the mutant Htt-expressing cells exhibited a defect in GABARAP autophagosome
biogenesis resulting in the reduced formation of these structures.
Overexpression of the UBL mutant, W58A-USP14, enhanced the formation of GABARAP positive autopha-
gosomes in the striatal cells but also affected their clearance as demonstrated by using chloroquine. Most
importantly, treatment with VER-155008 abrogated the USP14-mediated increase in GABARAP positive au-
tophagosomal structures, signifying involvement of HSC70 in this process. Our findings indicate that
HSC70 may have additional functions in the autophagy process beyond its established role in regulation
of chaperone-mediated autophagy and microautophagy. Further studies are warranted to understand
the dynamics of GABARAP and the importance of HSC70 and USP14 in autophagosome maturation.
In conclusion, we have identified proteasome-independent functions of USP14 in neuronal cells. USP14 interacts
with the chaperone HSC70 and the protein XBP1u with functional consequences for coordination of ER
signaling, upon proteasome inhibition and formation of GABARAP positive autophagosomes. We propose
that the interaction of USP14 with HSC70 studied here can be considered a molecular hub for mediating cross-
talk between the proteasome, ER stress signals, and autophagy in the cell (cartoon in graphical abstract). This
hub could be a target for future drug development in different diseases including HD. Impairment of protein
degradation involving the proteasomes as well as autophagy are key features of several human diseases
including HD. Our results, using mutant Htt-expressing striatal neuronal cells, indicate that these cells have a
defect in autophagy at the GABARAP sensitive stage of autophagosome maturation that can be influenced
by USP14 and HSC70 proteins. Modulation of the USP14-HSC70 axis using different compounds could be a
target for future drug development in neurodegenerative diseases including HD.Limitations of the Study
Protein homeostasis (proteostasis) is crucial for proper cell function and viability and is known to be
dysfunctional in several human diseases including cancer and neurodegenerative disorders. In our study,
we have employed proteomic analyses and cell cultures to depict a role of the deubiquitinating enzyme
USP14 in the control of proteostasis pathways via interaction with the chaperone, HSC70. Thereby we
used a cell model to investigate the dysregulation of proteostasis and autophagy in Huntington disease.
Further functional studies and in vivomodels of HD and other disorders are required to confirm the precise
role of the USP14-HSC70 axis in neuronal autophagy and in ER signaling as a possible target for modifying
disease pathology.METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.100790.iScience 23, 100790, January 24, 2020 15
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Supplemental Figure Legends 
 
 
Supplemental Figure 1 (Figure S1). Construction of p-ES-NTAP-Puro vector.  
Related to Figure 2. 
(A) The plasmid map of pCeMM-NTAP(GS)-Gw-Puro (p-ES-NTAP-Puro) is represented. Details of 
vector construction are described in the Materials and methods. 
(B) Expression of p-ES-NTAP-Puro-USP14 in SH-SY5Y cells was verified by immunostaining 
against USP14 (red). Nuclei were stained with Hoechst dye (blue). Scale bar- 100 µm. Right panel- 
expression of the p-ES-NTAP-Puro-USP14 was verified by immunoblotting with USP14 antibody. 
The arrowhead marks the overexpressed NTAP-USP14 protein migrating at ~80 kDa, showing 
similar expression level as an endogenous USP14 (at ~55 kDa) in both conditions. No band at ~80 
kDa is seen in SH-SY5Y cells expressing p-ES-NTAP-Puro vector only. 
 
Supplemental Figure 2 (Figure S2). The workflow depicting the affinity purification and 
bioinformatic analysis of USP14 interacting partners. Related to Figure 2. 
Retroviral infection compatible vector, pES-NTAP-Puro (USP14-NTAP-Puro) was utilized to infect 
SH-SY5Y cells and generate stably expressing clones upon puromycin selection. Cytoplasmic 
extracts were subjected to tandem affinity purification using dual affinity tags followed by FASP and 
tryptic digestion. Peptides were analyzed by tandem mass spectrometry and the results processed 
using Mascot and SAINT software. Contaminants were excluded based on the AvgP threshold 
resulting in a high confidence list of USP14-interacting partners (Supplemental Table 1). The 
identified interaction was further validated in Co-IP and functional experiments. 
Supplemental Table 1: SAINT analysis of USP14 interacting partners in pES-NTAP-Puro-USP14 stably expressing SHSYSY-5Y cells recovered by TAP-MS. Related to Figure 2. 
 
Bait Prey PreyGene Spec SpecSum AvgSpec NumReplicates ctrlCounts AvgP MaxP TopoAvgP TopoMaxP SaintScore logOddsScore FoldChange BFDR maxSpec PreyGeneID PreyGeneName Project_Frequency Shared_Frequency BioGrid 
USP14 HSP7C_HUMAN HSPA8 2|4 6 3 2 0|0 0,99 1 1 1 1 6,02 30 0 4 3312 HSPA8 76,92 100 novel 
USP14 IGHG2_HUMAN IGHG2 3|3 6 3 2 0|0 1 1 1 1 1 5,41 30 0 3 3501 IGHG2 92,31 100 TAP contaminant 
USP14 PRS4_HUMAN PSMC1 10|16 26 13 2 0|0 1 1 1 1 1 38,9 130 0 16 5700 PSMC1  100 reported 
USP14 PRS7_HUMAN PSMC2 7|11 18 9 2 0|0 1 1 1 1 1 31,4 90 0 11 5701 PSMC2 23,08 100 reported 
USP14 PRS6A_HUMAN PSMC3 4|11 15 7,5 2 0|0 1 1 1 1 1 25,77 75 0 11 5702 PSMC3 15,38 100 reported 
USP14 PRS8_HUMAN PSMC5 5|6 11 5,5 2 0|0 1 1 1 1 1 29,21 55 0 6 5705 PSMC5 15,38 100 reported 
USP14 PSMD1_HUMAN PSMD1 4|14 18 9 2 0|0 1 1 1 1 1 24,72 90 0 14 5707 PSMD1 15,38 100 reported 
USP14 PSMD2_HUMAN PSMD2 9|16 25 12,5 2 0|0 1 1 1 1 1 35,95 125 0 16 5708 PSMD2 15,38 100 reported 
USP14 PSMD3_HUMAN PSMD3 8|12 20 10 2 0|0 1 1 1 1 1 35,09 100 0 12 5709 PSMD3  100 reported 
USP14 PSMD4_HUMAN PSMD4 3|5 8 4 2 0|0 1 1 1 1 1 23,33 40 0 5 5710 PSMD4  100 reported 
USP14 HORN_HUMAN HRNR 8|4 12 6 2 0|3 0,84 0,96 0,69 0,9 0,84 -0,07 4 0 8 388697 HRNR 84,62 100 statistical contaminant 
USP14 ADRM1_HUMAN ADRM1 1|5 6 3 2 0|0 0,5 1 0,5 1 0,5 15,24 30 0,12 5 11047 ADRM1  100 reported 
USP14 PSA1_HUMAN PSMA1 0|2 2 1 2 0|0 0,49 0,99 0,5 1 0,5 3,59 10 0,28 2 5682 PSMA1  100 novel 
USP14 PSA2_HUMAN PSMA2 1|4 5 2,5 2 0|0 0,5 1 0,5 1 0,5 13,48 25 0,17 4 5683 PSMA2 7,69 100 reported 
USP14 PSA3_HUMAN PSMA3 1|4 5 2,5 2 0|0 0,5 1 0,5 1 0,5 16,29 25 0,17 4 5684 PSMA3  100 reported 
USP14 PSA5_HUMAN PSMA5 0|3 3 1,5 2 0|0 0,5 1 0,5 1 0,5 5,7 15 0,2 3 5686 PSMA5 15,38 100 reported 
USP14 PSA6_HUMAN PSMA6 0|3 3 1,5 2 0|0 0,5 1 0,5 1 0,5 8,51 15 0,2 3 5687 PSMA6  100 reported 
USP14 PSA7_HUMAN PSMA7 0|6 6 3 2 0|0 0,5 1 0,5 1 0,5 6,4 30 0,09 6 5688 PSMA7  100 novel 
USP14 PSB1_HUMAN PSMB1 0|2 2 1 2 0|0 0,49 0,99 0,5 1 0,5 5 10 0,28 2 5689 PSMB1  100 reported 
USP14 PSB5_HUMAN PSMB5 0|8 8 4 2 0|0 0,5 1 0,5 1 0,5 9,92 40 0,02 8 5693 PSMB5  100 reported 
USP14 PSB6_HUMAN PSMB6 0|3 3 1,5 2 0|0 0,5 1 0,5 1 0,5 7,11 15 0,2 3 5694 PSMB6  100 novel 
USP14 PSB7_HUMAN PSMB7 0|3 3 1,5 2 0|0 0,5 1 0,5 1 0,5 7,81 15 0,2 3 5695 PSMB7  100 novel 
USP14 PRS6B_HUMAN PSMC4 0|5 5 2,5 2 0|0 0,5 1 0,5 1 0,5 9,92 25 0,12 5 5704 PSMC4 23,08 100 reported 
USP14 PRS10_HUMAN PSMC6 1|8 9 4,5 2 0|0 0,5 1 0,5 1 0,5 16,64 45 0,02 8 5706 PSMC6  100 reported 
USP14 PSD11_HUMAN PSMD11 2|1 3 1,5 2 0|0 0,49 0,99 0,5 1 0,5 18,05 15 0,28 2 5717 PSMD11  100 reported 
USP14 PSD12_HUMAN PSMD12 0|3 3 1,5 2 0|0 0,5 1 0,5 1 0,5 5 15 0,2 3 5718 PSMD12 15,38 100 reported 
USP14 PSMD5_HUMAN PSMD5 2|1 3 1,5 2 0|0 0,49 0,99 0,5 1 0,5 13,13 15 0,28 2 5711 PSMD5  100 novel 
USP14 PSMD8_HUMAN PSMD8 0|2 2 1 2 0|0 0,49 0,99 0,5 1 0,5 2,89 10 0,28 2 5714 PSMD8  100 novel 
USP14 RS27A_HUMAN RPS27A 0|3 3 1,5 2 0|0 0,5 1 0,5 1 0,5 -0,97 15 0,2 3 6233 RPS27A 92,31 100 statistical contaminant 
Supplement Table Legend 
 
Supplemental Table 1. List of interacting partners in USP14 overexpressing 
neuroblastoma cells. Related to Figure 2. 
 
Tandem affinity analyses of USP14 interacting proteins were done as described in Transparent 
Methods section. Peptides obtained were analyzed using Mascot and SAINT software. Contaminants 
were excluded based on the AvgP threshold resulting in a high confidence list of USP14-interacting 
partners.  Several  proteasome  interactors  of  USP14  have  been  reported,  whilst  the  binding    
to HSPA8/HSC70 was previously unrecognized. 
Transparent Methods 
Cell culture and transfections 
SH-SY5Y human and Neuro2A mouse neuroblastoma cells were cultured in Dulbecco’s Modified 
Eagle Medium (DMEM) (Lonza) supplemented with 10% fetal bovine serum (Gibco), 7.5% 
NaHCO3, 100 mM NA-glutamine (Gibco) and 100 mM penicillin-streptomycin (Gibco) at 37°C in 
5% CO2. Striatal cell lines (kind gift from Prof. Tönis Timmusk, Tallin University of Technology, 
Estonia) derived from mice expressing different huntingtin (Htt) genotypes and immortalized with a 
temperature sensitive large T antigen were used as previously described (Kannike et al., 2014). 
Control cells expressed 7-polyglutamine (7Q) repeats while the mutant cells expressed 109- 
polyglutamine (109Q) repeats. Cells were cultured in DMEM supplemented with 10 % fetal bovine 
serum (Gibco), 7.5% NaHCO3, 100 mM NA-glutamine (Gibco) and 100 mM penicillin-streptomycin 
(Gibco) at 33°C in 5% CO2. 
Primary neuron cultures were obtained from brain cortices of embryonic E17-old rat pups, and 
cultured as described (Do et al., 2013). Briefly, the cortices were enzymatically dissociated by trypsin 
and further processed using DNase I (Roche). The solution was then centrifuged and the pellet 
resuspended in fresh Neurobasal solution (Gibco). The appropriate number of cells were plated onto 
cell culture dishes coated with poly-L-ornithine (Sigma) and cultured in Neurobasal (Gibco) medium 
supplemented with 50x B27 (Gibco), 25 mM glutamine (Gibco) and 100 mM penicillin-streptomycin 
(Gibco) at 37°C in 5% CO2. Half of the medium was replaced every two days and cells were incubated 
for 8 days before experiments. 
Different compounds were added to the cells, including 20 µM MG132 (Calbiochem), 0.5 µM 
bortezomib (Calbiochem) or 5 µM Lactacystin (Sigma) for 5-6 h to inhibit the proteasome. To inhibit 
autophagy, 200 nM bafilomycin A1 (Sigma) or 50 µM chloroquine (Sigma) were added for 5 h and 
to block the activity of HSC70, 25 or 50 µM VER-155008 (Tocris Biosciences) was added for 24 h. 
In some experiments, 2.5 µg/ml tunicamycin (Sigma) was added for 6 h to induce the unfolded protein 
response (UPR). Linear Polyethylenimine 25.000 (PEI) (Polysciences, Inc.) was used for transient 
transfection of neurons based on the manufacturer’s instructions. PEI was prepared at a stock 
concentration of 1 mg/ml. DNA and PEI were combined at a ratio of 1:3 for complexing. Following 
24 - 48 h of transfection, different treatments were applied as above. 
 
Cell viability assay 
Cell viability was assayed essentially as described previously (Hyrskyluoto et al., 2013). In brief, 
striatal cells expressing 7Q or 109Q Htt protein were treated with 25 µM or 50 µM VER-155008 for 
24 h and cell death was measured by utilizing tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide (MTT, Sigma) substrate added to cells for 2 h. The insoluble formazan 
substrate was then reconstituted in a solvent of 0.1 M HCl-isopropanol and incubated for 30 min. 
with gentle agitation. Absorbance was measured at 560 nm and the value reflected the relative number 
of surviving cells following each treatment. 
 
Expression vectors cDNAs and transfection 
Wild type human pRK-FLAG-USP14 (Flag-WT-USP14) and mutant pRK-FLAG-USP14 C114A 
plasmids were a kind gift from Dr Yihong Ye (Wang et al., 2006). XBP1 (Myc-DDK-tagged)-Human 
X-box binding protein 1 (XBP1), transcript variant 1 (hereafter referred to as XBP1u) was obtained 
from Origene. pcDNA5/FRT/TO-GFP-HSPA8 (GFP-WT-HSC70), Flag-HA-GFP and Flag-HA- 
USP14 were obtained from Addgene. eGFP-WT-USP14 (GFP-WT-USP14) was generated by 
amplifying USP14 cDNA from pRK-FLAG-WT-USP14 and subcloning it into eGFPC1 vector. 
pDestEGFP-GABARAP (EGFP-GABARAP) plasmid was a kind gift from Dr. Nikolai Engedal 
(University of Oslo, Norway). The point mutation of WT-USP14 to W58A-USP14 was made using 
the QuickChange lightning site-directed mutagenesis kit (Stratagene) following the manufacturer’s 
instructions. 
 
pCeMM-NTAP(GS)-Gw-Puro cloning strategy 
The details of pCeMM-CTAP(GS)-Gw-Puro (pES-CTAP) vector preparation were previously 
described (Scifo et al., 2013). In the first step, a fragment containing the IRES sequence and the 
puromycin ORF was amplified from pES-CTAP via PCR using the following primers: 5'- 
gttattttccaccatattgccg (5'-IRES_puro) and 5'-tcctccaccggtacgcgtcaggcaccgggcttgcg (IRES_puro-3'; 
AgeI and MluI sites are underlined). The PCR fragment was then digested with AvrII (singular site 
in IRES) and AgeI (introduced by the PCR primer). This fragment was then ligated into the AvrII- 
BspEI site of the vector pCeMM-NTAP(GS)Gw (Burckstummer et al., 2006), thus replacing IRES- 
GFP by IRES-Puro casette from pES-CTAP vector. To achieve it, IRES-GFP was first removed from 
pCeMM-NTAP-GS-Gw by digesting the vector with AvrII (singular site in IRES) and Kpn2I 
(isoschizomer of BspEI, partial digest) thus isolating the BspEI (nt 1348) – AvrII vector band (size 
7.4 kb). Potential clones were sequence verified using the following primers: 5'-gttattttccaccatattgccg 
(5'-IRES_puro) and 5'-caccgagctgcaagaactc (ML_Seq_1). The sequence and map of the pCeMM- 
NTAP(GS)-Gw-Puro vector are provided in the supplemental material. 
Full length USP14 (OCAAo5051F0231D) sequence verified entry clone in pENTR221 vector, 
purchased from Source Biosource (OCAAo5051F0231D) was shuttled into pES-NTAP-Puro, for 
TAP-MS experiments, as described (Scifo et al., 2013). Recombination of DNA fragments was 
performed using the LR clonase reaction (Life Technologies Europe BV, Espoo, Finland) and 
analyzed with BsrGI restriction enzyme. 
 
Construct for shRNA against USP14 
SHC002 Non-Mammalian (scramble shRNA) Negative control and constructs against human USP14 
were purchased from TRC1 library in a backbone of pLKO.1 vector (Sigma). Five shRNA constructs 
were tested for efficient USP14 knockdown (KD) by immunoblotting for USP14 and the best 
constructs were then chosen for generation of SH-SY5Y USP14 KD cells. These constructs were 
TRCN0000007425 (USP14 shRNA1) and TRCN0000007428 (USP14 shRNA2). 
 
Generation of SH-SY5Y human neuroblastoma cells with knockdown of USP14 
Lentivirus particles expressing shRNA constructs were generated at the Biomedicum Functional 
Genomics Unit, University of Helsinki, Finland. SH-SY5Y cells were seeded into 6-well plates and 
transduced with lentiviral particles containing shRNA the following day. Following 48 h of virus 
infection, the antibiotic selection was performed by changing medium with fresh DMEM containing 
1 µg/ml puromycin (Gibco, Life technologies). The shRNA constructs exhibiting the best USP14 KD 
efficiency were further chosen for expansion, referred to as USP14 shRNA1 and USP14 shRNA2 
cell clones. SH-SY5Y cells transduced with scramble shRNA expressing viruses were used as a 
control. Selection pressure with puromycin was maintained during propagation and the medium was 
changed every 3 days with fresh DMEM containing puromycin. 
 
TAP purification 
Monolayer cells were harvested from three 150 mm plates of USP14-NTAP-Puro or NTAP-Puro 
infected SH-SY5Y cells, grown to 80% confluency (1 × 108 cells). Preparation of cytoplasmic extract 
from the cells was performed as previously described (Scifo et al., 2013), while the TAP purification 
procedure followed by FASP preparation prior to MS analysis as in (Scifo et al., 2015a). The Lys-C 
and trypsin peptide digests were processed on Zip-Tip C18 reversed phase (Merck Millipore) 
according to manufacturer protocol. Peptide digests were resuspended in 1% TFA and sonicated in a 
water bath for 1 min. The peptide mixture was applied onto a C-18 reverse phase pre-column 
(nanoACQUITY Symmetry® C18, Waters) using 0.1% TFA as mobile phase and then separated on 
a nano-UPLC C-18 column (nanoACQUITY BEH C18, Waters) with an 0.05% formic acid in a 
gradient of acetonitrile (0–35% ACN in 182 min), at a flow rate of 250 nl/min, and analyzed on Q 
Exactive™Hybrid Quadrupole-Orbitrap (Thermo Scientific), as described (Scifo et al., 2015a). 
MS/MS peak lists or spectral data were searched with the Mascot Daemon interface (version 2.4.0; 
Matrix Science, Uni. of Helsinki) against the Swiss-Prot 2018_05 database (20350 sequences), with 
taxonomy set to Homo sapiens. Carbamidomethyl-Cys, met oxidation and N/Q residues deamidation 
were used as fixed and variable modifications, respectively. Mass tolerance of the precursor ions was 
set to 20 ppm, and of MS/MS fragment ions to 0.5 Da. The peptide charges were set to 1-3, and 2 
tryptic mis-cleavages were allowed. SAINT analysis was performed as previously described (Scifo 
et al., 2013), except that two biological replicates were used for the bait (USP14) and negative control 
(empty pES-NTAP-Puro vector). Protein hits that passed the threshold of an AvgP ≥0.5 were 
considered as true USP14 interactors, after exclusion of an empty pES-NTAP-Puro vector 
contaminants (Scifo et al., 2013; Scifo et al., 2015a, b), statistical contaminants (www.crapome.org) 
and checking for those matching the list of previously identified USP14 interacting partners (see 
compendium in BioGRID 3.5 database; Biogrid/homo-sapiens/usp14). 
 
Immunoprecipitation 
Cells were lysed in a modified RIPA lysis buffer containing 50 mM Tris-HCl pH 7.7, 150 mM NaCl, 
1% NP-40, and 0.5% sodium deoxycholate for 30 min. on ice. Following the lysis, the tubes were 
rotated for 15-30 min. at 4°C and centrifuged at 10,000g for 10 min. at 4°C. The supernatant was 
collected, and protein concentration was measured using the BCA protein assay kit (Pierce, Thermo 
Fisher Scientific). Equal amounts of protein lysates were taken and precleared using 20 µl of 
prewashed Protein A/G agarose beads (Sigma) for one hour at 4°C. Pre-cleared lysate was incubated 
with the Anti-Flag M2 (Sigma) or Anti-USP14 (Sigma) overnight in a rotor at 4°C. The following 
day, BSA blocked agarose beads were added to the overnight antibody conjugated lysate mixture and 
was left to rotate at 4°C for 2-3 h. The antibody complexed beads were centrifuged at 9000xg for 1 
min. at 4°C and washed with the lysis buffer 3-4 times on a rotator at 4°C, 5 min. each. 
Immunoprecipitated proteins were eluted by adding 35 µl of 2x denaturing Laemmli buffer and heated 
at 95°C for 5 min. The heat-denatured samples were centrifuged for 3 min. at 10.000xg and the 
supernatant was collected. The 35 µl supernatant was loaded to PAGE and the immunoprecipitated 
complexes were analyzed using Western blot for detecting the immunoprecipitated protein and its 
interacting partners. 40 µg of lysate was used as the input control. 
 
Immunoblotting 
Cells were washed twice with ice-cold PBS and lysed in RIPA buffer (150 mM NaCl, 1% Triton-X- 
100, 0.5% sodium deoxycholate, 1% SDS, 50 mM Tris-HCl, pH 7.4) supplemented with protease 
inhibitors (Roche) and phosphatase inhibitor (Phosphostop, Roche). Protein concentration 
measurements were performed with the BCA protein assay kit (Pierce, Thermo Fisher Scientific), 
and equal amounts of protein were loaded to PAGE and blotted onto nitrocellulose membrane filters 
(Amersham Biosciences, Helsinki, Finland). The membranes were incubated for 1h in 5% skimmed 
milk or 5% bovine serum albumin, in TBS-T (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% Tween 
20) and then with the primary antibodies overnight at 4°C with gentle agitation. Primary antibodies 
used were as follows: anti-USP14 (1:500, Abgent, AP2142a); anti-USP14 (1:1000, Sigma, J6111- 
6D6); anti-HSC70 (1:2000, SantaCruz Biotechnology, sc7298); anti-XBP1 (detects both XBP1s 
running at 56 kDa and XBP1u, at 29 kDa as indicated in respective IBs and figure legends), 1:2000, 
Cell signaling technologies, D2C1F); anti-Actin (1:10000,Sigma, A2066); Anti-GFP (1:2000, Sigma, 
11814460001); anti-Flag (1:2000, Sigma); Anti-pIRE1α (phosphor S724; 1:2500, Abcam, ab48187), 
Anti-IRE1α (1:2500, Abcam, ab37073); Anti-PSMD2 (1:1000, Thermo Fisher Scientific); anti- 
GABARAP (E14JE) (1:2000, CST, 13733). Following washes, the membranes were incubated with 
horseradish peroxidase-conjugated secondary antibodies (1:2500, Jackson Immunoresearch 
Laboratories) at room temperature for 1 h with gentle agitation. Protein signals were detected using 
enhanced chemiluminescence substrate (Pierce, Thermo Fisher Scientific). Immunoblots were 
quantified with ImageJ (NIH) quantification software. 
 
Immunocytochemistry 
SH-SY5Y cells or Striatal neuronal cells plated on coverslips were fixed using 4% paraformaldehyde 
at RT for 10 min. Fixed cells were permeabilized with 0.1% Triton-X-100 containing phosphate 
buffered saline (PBS-T) and blocked with 5% bovine serum albumin (Sigma) diluted in PBS-T for 1 
h. The cells were incubated in XBP1u antibody (1:500; SAB2102720, Sigma) diluted in 5% BSA 
containing PBS-T overnight at 4°C. The coverslips were washed in PBS-T and incubated with 
fluorophore conjugated Alexa Fluor® 488 or 594 secondary antibody diluted in 5% BSA containing 
PBS-T (1:600, Invitrogen) for 2 h in dark at room temperature. Subsequently, the coverslips were 
washed in PBS-T and nuclei stained with Hoechst 33342 (Thermo Fisher Scientific, 62249). The 
coverslips were mounted onto glass slides with Mowiwol (Calbiochem) containing DABCO gel 
mounting media. The cells were imaged using Zeiss Axioplan2 imaging universal light microscope. 
 
Live cell imaging for EGFP-GABARAP positive autophagic structures 
Striatal neuronal cells transfected with EGFP-GABARAP in combination with empty vector or Flag- 
W58A-USP14 were imaged using the EVOS FL cell imaging system (Thermo Fisher Scientific) with 
a 40X objective. Imaging of GABARAP positive autophagosome at a higher resolution was 
performed using a Nikon Eclipse Ti-E inverted widefield microscope with full environmental 
chamber, Hamamatsu Orca Flash 4.0 V2 B&W camera for fluorescence and Lumencor Spectra X 
light engine (Biomedicum imagine unit, Medicum, University of Helsinki). Briefly, striatal neurons 
were plated on µ-Slide ibiTreat polymer bottom plates (80826, ibidi, Germany) and transfected with 
EGFP-GABARAP in combination with empty vector or Flag-W58A-USP14. Following the treatment 
with VER-155008 (25µM, 24 h) or DMSO, cells were imaged with a 100X Plan Apo VC objective 
(Numerical aperture, 1.40) and LED-FITC-A filter. Images were acquired using NIS-Elements 
advanced research with 6D image acquisition module software from Nikon. 
Each experiment contained images from several fields of view. Acquired images were analyzed by 
ImageJ particle analysis. 
 
Analysis for XBP1u ALIS and EGFP-GABARAP positive structures 
XBP1u ALIS and EGFP-GABARAP autophagic structures were considered as particles and analyzed 
using ImageJ ComDet v.0.4.1 plugin. Briefly, the region of interest (ROI) was defined around the 
cell boundary. The plugin was applied to the defined ROI to obtain the number of particles and their 
respective integrated intensities. To negate the cell size dependent differences in the number of 
particles, average integrated intensity/particle was obtained and used as a measure of changes in 
XBP1u ALIS or EGFP-GABARAP signal intensities between samples. 
 
Deubiquitination activity assay 
The assay was performed as described earlier with a few modifications (Borodovsky et al., 2002). 
Neuro2A cells overexpressing Flag-WT-USP14, Flag-C114A-USP14, and Flag-W58A-USP14 were 
lysed in 50 mM Tris (pH 7.4), 250 mM sucrose, 5 mM MgCl2, 1mM DTT and 1mM ATP for 1h at 
4°C. 50 µg of lysates was then incubated with 3 mM ubiquitin vinyl methyl ester (HA tag; Enzo Life 
Science) for 3 h at 37°C. The samples were then boiled 95°C for 5 min in denaturing Laemmli buffer 
and analyzed by immunoblotting with anti-Flag antibodies. 
 
RNA isolation and Quantitative PCR 
RNA was extracted from control 7Q and mutant 109Q expressing striatal cells using the RNeasy mini 
kit (Qiagen). cDNA was synthesized with SuperScript VILO (Invitrogen, Thermo Fisher Scientific 
Scientific) following the manufacturer’s instructions. LightCycler 480 SYBR Green I MASTER 
(Roche Applied Science) was utilized to perform real time quantitative PCR on a LightCycler 480 
(Roche Applied Science) with a 96-well block as described previously (Pham et al., 2016; Pham et 
al., 2019). PCR conditions were as follows: Initial incubation at 95 °C for 15 min, followed by 40 
cycles at 95 °C for 15 s, 63 °C for 20 s and 72 °C for 10 s. Each sample was analyzed in triplicates 
and from three independent experiments and normalized to glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) using the ΔΔCt (threshold cycle) method. The amplified product was 
checked by melting curve analysis spanning the temperature range from 65 °C to 95 °C with a 
ramping rate of 0.03 °C/s. The following primer sequences were used: USP14, forward, 
5’GGCGAACAAGGGCAGTATC3’, and reverse, 5’TCTGTTGCAGGACTCTCATCA3’; 
GAPDH, forward, 5’GGGTTCCTATAAATACGGACTGC3’, and reverse, 
5’CCATTTTGTCTACGGGACGA3’. 
Statistical analysis 
Statistical comparison was performed using Student’s t-test or one-way/two-way ANOVA, 
depending on the experimental design. p value, p < 0.05 was considered as statistically significant. 
Statistical analysis and graph design were performed using GraphPad PRISM software. 
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